Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 35, 2003 - Issue 6-7
Submit an article Journal homepage
123
Views
24
CrossRef citations to date
0
Altmetric
Research Article

Six Cases of Lactobacillus Bacteraemia: Identification of Organisms and Antibiotic Susceptibility and Therapy

Magnus Arpi Århus University Hospital Skejby Århus
,
Marc Vancanneyt BCCM/LMG Bacteria Collection University of Gent Gent
,
Jean Swings BCCM/LMG Bacteria Collection University of Gent Gent
&
Jørgen J. Leisner Department of Veterinary Microbiology Royal Veterinary and Agricultural University Frederiksberg
Pages 404-408 | Published online: 08 Jul 2009

References

  • Klein G, Pack A, Bonaparte C, Reuter G. Taxonomy and physiology of probiotic lactic acid bacteria. Int J Food Microbiol 1998; 41: 103–25.
  • Sussman JI, Baron EJ, Goldberg SM, Kaplan MH, Pizzarello RA. Clinical manifestations and therapy of Lactobacillusendocarditis: report of a case and review of the literature. Rev Infect Dis 1994; 8: 771–6.
  • Griffiths JK, Daly JS, Dodge RA. Two cases of endocarditis due to Lactobacillus species: antimicrobial susceptibility, review, and discussion of therapy. Clin Infect Dis 1992; 15: 250–5.
  • Aguirre M, Collins MD. Lactic acid bacteria and human clinical infection. J Appl Bacteriol 1993; 75: 95–107.
  • Kalima P, Masterton RG, Hoddie PH, Thomas AE. Lactobacillus rhamnosus infection in a child following bone marrow transplant. J Infect 1996; 32: 165–7.
  • Saxelin M, Chuang NH, Chassy B, Rautelin H, Mäkelä PH, Salminen S, Gorbach SL. Lactobacilli and bacteremia in southern Finland, 1989–1992. Clin Infect Dis 1996; 22: 564–6.
  • Fruchart C, Salah A, Gray C, Martin E, Stamatoullas A, Bonmarchand G, et al. Lactobacillus species as emerging pathogens in neutropenic patients. Eur J Clin Microbiol Infect Dis 1997; 16: 681–4.
  • Husni RN, Gordon SM, Washington JA, Longworth DL. Lactobacillus bacteremia and endocarditis: review of 45 cases. Clin Infect Dis 1997; 25: 1048–55.
  • Klein G, Zill E, Schindler R, Louwers J. Peritonitis associated with vancomycin-resistant Lactobacillus rhamnosus in a continuous ambulatory peritoneal dialysis patient: organism identification, antibiotic therapy and case report. J Clin Microbiol 1998; 36: 1781–3.
  • Felten A, Barreau C, Bizet C, Lagrange PH, Philippon A. Lactobacillus species identification, H2O2 production, and antibiotic resistance and correlation with human clinical status. J Clin Microbiol 1999; 37: 729–33.
  • Jureen R, Søndenaa K, Høiby EA, Digranes A. Lactobacillus rhamnosus septicaemia in a patient with a graft in the inferior vena cava. Scan J Infect Dis 2002; 34: 135–6.
  • Presterl E, Kneifel W, Mayer HK, Zehetgruber M, Makristathis A, Graninger W. Endocarditis by Lactobacillus rhamnosus due to yogurt ingestion? Scand J Infect Dis 2001; 33: 710–4.
  • Salminen MK, Tynkkynen S, Rautelin H, Saxelin M, Vaara M, Ruutu P, et al. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis 2002; 35: 1155–60.
  • Gallemore GH, Mohon RT, Ferguson DA. Lactobacillus fermentum endocarditis involving a native mitral valve. J Tennessee Med Assoc 1995; 88: 306–8.
  • Rautio M, Jousimies-Somer H, Kauma H, Pietarinen I, Saxelin M, Tynkkynen S, Koskela M. Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus GG. Clin Infect Dis 1999; 28: 1159–60.
  • Difco Laboratories. Difco manual, 10th edn. Detroit, MI: Difco Laboratories; 1984. p. 1071.
  • Pot B, Vandamme P, Kersters K. Analysis of electrophoresis whole-cell organisms protein fingerprints. In: Goodfellow M, O’Donnel AG, eds. Chemical methods in procaryotic systematics. Chichester: John Wiley; 1994. p. 493–521.
  • Pot B, Janssens D. The potential of a culture collection for identification and maintenance of lactic acid bacteria. In: Foo EL, Griffin HG, Mollby R, Heden CG, eds. The lactic acid bacteria. Proceedings of the First Lactic Acid Bacteria Computer Conference. Norfolk, VA: Horizon Scientific Press; 1993. p. 81–7.
  • Hammes WP, Vogel RF. The genus Lactobacillus. In: Wood BJB, Holzapfel WH, eds. The lactic acid bacteria, vol. 2. The genera of lactic acid bacteria. London: Blackie; 1995. p. 19–54.
  • Hamilton-Miller JMT, Shah S. Vancomycin susceptibility as an aid to the identification of lactobacilli. Lett Appl Microbiol 1998; 26: 153–4.
  • Antony SJ, Stratton CW, Dummer JS. Lactobacillus bacteremia: description of the clinical course in adult patients without endocarditis. Clin Infect Dis 1996; 23: 773–8.
  • Herra CM, Cafferkey MT, Keane CT. The in-vitro susceptibilities of vaginal lactobacilli to four broad spectrum antibiotics, as determined by the agar dilution and E-test methods. J Antimicrob Chemother 1995; 35: 775–83.
  • Arpi M, Jensen KT, Frederiksen W. Yersinia enterocolitica bacteremia: an analysis of thirty-six patients in Denmark and a review of the literature. Contrib Microbiol Immunol 1991; 12: 260–4.
  • Kanwar YS, Malhotra V, Anderson BR, Pilz CG. Salmonellosis associated with abdominal aortic aneurysm. Arch Intern Med 1974; 134: 1095–8.
  • Harty DWS, Oakey HJ, Patrikakis M, Hume EBH, Knox KW. Pathogenic potential of lactobacilli. Int J Food Microbiol 1994; 24: 179–89.

References

  • Benchekroun A, Lakrissa A, Essakalli N, Abakka T, Faik M, Hachimi M, Marzouk M. Hydatid cysts of the kidney, apropos of 30 cases. J Urol 1986; 92: 171–6.
  • Afsar H, Yagci F, Aybasti N, Meto S. Hydatid disease of the kidney. Br J Urol 1994; 73: 17–22.
  • Von Sinner WN, Hellström M, Kagevi I, Norlen BJ. Hydatid disease of the urinary tract. J Urol 1993; 149: 577–80.
  • Shetty SD, Al Saigh A, Ibrahim AIA, Patil KP, Bhattacham CL. Management of hydatid cysts of the urinary tract. Br J Urol 1992; 70: 258–61.
  • Poulios C. Echinococcal disease of the urinary tract: review of the management of 7 cases. J Urol 1991; 145: 924–7.
  • Angulo JC, Escribano J, Diego A, Sanchez-Chapado M. Isolated retrovesical and extrarenal retroperitoneal hydatosis: clinical study of 10 cases and literature review. J Urol 1998; 159: 76–82.
  • Turan T, Tuncay L, Kayik S, Atahan O, Aybek Z. Retrovesical hydatid cyst. J Urol 1998; 159: 2085–8.
  • Burgos FJ, Tallada M, Hernandez C, Perales L, Perez De Oteyza J. Quiste hidatidico retrovesical con fistulizacion espontanea a sigma. Actas Urol Esp 1986; 10: 367–70.
  • Whyman MR, Morris DL. Retrovesical hydatid causing haemospermi. Br J Urol 1991; 68: 100–1.
  • Clements R, Bowyer FM. Hydatid disease of the pelvis. Clin Radiol 1986; 37: 375–7.
  • Pistolesi GF, Procacci C, Caudan R, Bergamo IA, Manera V, Recla M, et al. CT criteria of the differential diagnosis in primary retroperitoneal masses. Eur J Radiol 1984; 4: 127–38.
  • Mukherjee S, Nigam M, Saraf JC. Primary retroperitoneal hydatid cyst. Br J Surg 1973; 60: 916–8.

References

  • Puliafito CA, Baker AS, Haff J, Foster CS. Infectious endophthalmitis: review of 36 cases. Ophthalmology 1982; 89: 921–9.
  • Miller JM, Novy C, Hiott M. Case of bacterial endophthalmitis caused by an Agrobacterium radiobacter-like organism. J Clin Microbiol 1996; 34: 3212–3.
  • Potvliege C, Vanhuynegem L, Hansen W. Catheter infection caused by an unusual pathogen, Agrobacterium radiobacter. J Clin Microbiol 1989; 27: 2120–2.
  • Plotkin GR. Agrobacterium radiobacter prosthetic valve endocarditis. Ann Intern Med 1980; 93: 839–40.
  • Landron C, Le Moal G, Roblot F, Grignon B, Bonnin A, Becq-Giraudon B. Central venous catheter-related infection due to Agrobacterium radiobacter: a report of 2 cases. Scand J Infect Dis 2002; 34: 693–4.

References

  • Lin RD, Hsueh PR, Chang JC, Teng LJ, Chang SC, Ho SW, et al. Flavimonas oryzihabitans bacteremia: clinical features and microbiological characteristics of isolates. Clin Infect Dis 1997; 24: 867–73.
  • Esteban J, Valero-Moratalla ML, Alcazar R, Soriano F. Infections due to Flavimonas oryzihabitans: case report and literature review. Eur J Clin Microbiol Infect Dis 1993; 12: 797–800.
  • Bendig JW, Mayes PJ, Eyers DE, Holmes B, Chin TT. Flavimonas oryzihabitans (Pseudomonas oryzihabitans; CDC group Ve-2): an emerging pathogen in peritonitis related to continuous ambulatory peritoneal dialysis? J Clin Microbiol 1989; 27: 217–8.
  • Qian K, Wang S. Infections caused by Flavimonas oryzihabitans. Chin Med J (Engl) 2001; 114: 394–8.
  • Marin M, Garcia de Viedma D, Martin-Rabadan P, Rodriguez-Creixems M, Bouza E. Infection of Hickman catheter byPseudomonas (formerly flavimonas) oryzihabitans traced to a synthetic bath sponge. J Clin Microbiol 1997; 38: 4577–9.
  • Kansouzidou A, Charitidou C, Poubrou E, Daniilidis VD, Tsagaropoulou H. Haemorrhagic papular rash associated to Flavimonas oryzihabitans bacteraemia in a child. Eur J Epidemiol 2000; 16: 277–9.
  • Castagnola E, Conte M, Venzano P, Garaventa A, Viscoli C, Barretta MA, et al. Broviac catheter-related bacteraemias due to unusual pathogens in children with cancer: case reports with literature review. J Infect 1997; 34: 215–8.
  • Verhasselt B, Claeys G, Elaichouni A, Verschraegen G, Laureys G, Vaneechoutte M. Case of recurrent Flavimonas oryzihabitans bacteremia associated with an implanted central venous catheter (Port-A-Cath): assessment of clonality by arbitrarily primed PCR. J Clin Microbiol 1995; 33: 3047–8.
  • Conlu A, Rothman J, Staszewski H, Schoch PE, Domenico P, Quadri SM, Cunha BA. Flavimonas oryzihabitans (CDC group Ve-2) bacteraemia associated with Hickman catheters. J Hosp Infect 1992; 20: 293–9.
  • Mutters R, Koppler H, Krause T. Isolation of Flavimonas oryzihabitans (CDC group Ve-2) from catheter-induced bacteremia in an immunocompromised patient. Eur J Epidemiol 1990; 6: 436–7.
  • Munro R, Buckland G, Neville S. Flavimonas oryzihabitans infection of a surgical wound. Pathology 1990; 22: 230–1.
  • Rolston KV, Ho DH, LeBlanc B, Bodey GP. In vitro activities of antimicrobial agents against clinical isolates of Flavimonas oryzihabitans obtained from patients with cancer. Antimicrob Agents Chemother 1993; 37: 2504–5.
  • Decker CF, Simon GL, Keiser JF. Flavimonas oryzihabitans (Pseudomonas oryzihabitans; CDC group Ve-2) bacteremia in the immunocompromised host. Arch Intern Med 1991; 151: 603–4.
  • Podbielski A, Mertens R, Ziebold C, Kaufhold A. Flavimonas oryzihabitans septicaemia in a T-cell leukaemic child: a case report and review of the literature. J Infect 1990; 20: 135–41.
  • Anzai Y, Kudo Y, Oyaizu H. The phylogeny of the genera Chryseomonas, Flavimonas, and Pseudomonas supports synonymy of these three genera. Int J Syst Bacteriol 1997; 47: 249–51.

References

  • Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM, Schlievert PM, Kaplan E. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989; 321: 1–7.
  • Cone LA, Woodard DR, Schlievert PM, Tomory GS. Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N Engl J Med 1987; 317: 146–9.
  • Kaul R, McGeer A, Low DE, Green K, Schwartz B. Population-based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study. Am J Med 1997; 103: 18–24.
  • Zurawski CA, Bardsley M, Beall B, Elliott JA, Facklam R, Schwartz B, Farley MM. Invasive group A streptococcal disease in metropolitan Atlanta: a population-based assessment. Clin Infect Dis 1998; 27: 150–7.
  • Ruben FL, Norden CW, Heisler B, Korica Y. An outbreak of Streptococcus pyogenes infections in a nursing home. Ann Intern Med 1984; 101: 494–6.
  • DiPersio JR, File TM Jr, Stevens DL, Gardner WG, Petropoulos G, Dinsa K. Spread of serious disease-producing M3 clones of group A streptococcus among family members and health care workers. Clin Infect Dis 1996; 22: 490–5.
  • Gamba MA, Martinelli M, Schaad HJ, Streuli RA, DiPersio J, Matter L, et al. Familial transmission of a serious disease producing group A streptococcus clone: case reports and review. Clin Infect Dis 1997; 24: 1118–21.
  • Davies HD, McGeer A, Schwartz B, Green K, Cann D, Simor AE, Low DE. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med 1996; 335: 547–54.
  • Charytan D. Invasive group A streptococcal infections. N Engl J Med 1997; 336: 513.
  • The Meningococcal Disease Surveillance Group. Meningococcal disease. Secondary attack rate and chemoprophylaxis in the United States, 1974. JAMA 1976; 235: 261–5.

References

  • Cohen JI, Bartlett JA, Corey GR. Extra-intestinal manifestations of salmonella infections. Medicine (Baltimore) 1987; 66: 349–88.
  • Parsons R, Gregory J, Palmer DL. Salmonella infection of the abdominal aorta. Rev Infect Dis 1983; 5: 227–31.
  • Salzberger LA, Cavuoti D, Barnard J. Fatal Salmonella aortitis with mycotic aneurysm rupture. Am J Forensic Med Pathol 2002; 23: 382–5.
  • Simon DR, Wishnow RM. An unusual presentation of salmonellal aortitis. South Med J 1991; 84: 657–9.
  • Morrow C, Safi H, Beall AC Jr. Primary aortoduodenal fistula caused by Salmonella aortitis. J Vasc Surg 1987; 6: 415–8.
  • Cohen PS, O’Brien TF, Schoenbaum SC, Medeiros AA. The risk of endothelial infection in adults with Salmonella bacteraemia. Ann Intern Med 1978; 89: 931–2.
  • Carrreras M, Larena JA, Tabernero G, Langara E, Pena JM. Evolution of salmonella aortitis towards the formation of abdominal aneurysm. Eur Radiol 1997; 7: 54–6.
  • Oskoui R, Davis WA, Gomes MN. Salmonella aortitis; a report of a successfully treated case with a comprehensive review of the literature. Arch Intern Med 1993; 153: 517–25.
  • Soravia-Dunand VA, Loo VG, Salit IE. Aortitis due to Salmonella: report of 10 cases and comprehensive review of the literature. Clin Infect Dis 1999; 29: 862–8.
  • Tan HC, Chan RKT, Tan WC. Fatal haemoptysis in Salmonella typhimurium septicaemia – a cautionary tale. Singapore Med J 1994; 35: 525–6.
  • Chung SL, Ding YA. Fatal haemoptysis in dissecting aortic aneurysm and salmonellosis: a case report. Zhonghua Yi Xue Za Zhi (Taipei) 1999; 62: 817–22.

References

  • Salomon H. Ueber meningokokkenseptikamie. Berl Klin Wschr 1902; 39: 1045–8.
  • Dock W. Intermittent fever of seven months duration due to meningococcemia. JAMA 1924; 83: 31–3.
  • Day WR. Chronic meningococcemia in infancy. Northwest Med 1961; 60: 915–6.
  • Hvilested RL. Kronisk meningokokæmi (chronic meningococcemia). Ugeskrift Laeger 1991; 153/51: 3613–4.
  • Benoit FL. Chronic meningococcemia. Am J Med 1963; 35: 103–12.
  • Leibel LR. Chronic meningococcemia in childhood. Am J Dis Child 1974; 127: 94–8.
  • Kruijtzer CMF, Buiting AGM, Graafsma SJ. Chronic meningococcaemia: a case report. Neth J Med 1997; 50: 102–4.
  • Davidson F. Chronic meningococcaemia. Aust NZ J Med 1998; 28: 833–4.
  • Prins JM, Lauw FN, Derkx BHF, Speelman P, Kuijpers EJ, Dankerts J, Van Deventer SH. Endotoxin release and cytokine production in acute and chronic meningococcaemia. Clin Exp Immunol 1998; 114: 215–9.
  • Goldbloom AA. Meningococcic infections in an army staging area. Ann Intern Med 1946; 24: 589–605.
  • Schaad UB. Arthritis in disease due to Neisseria meningitides. Rev Infect Dis 1980; 2: 880–8.

References

  • Chiao EY, Ries KM, Sande MA. AIDS and the elderly. Clin Infect Dis 1999; 28: 740–5.
  • Sudre P, Rickenbach M, Taffe P, Janin P, Volkart AC, Francioli P. Swiss HIV Cohort Study. Clinical epidemiology and research on HIV infection in Switzerland: the Swiss HIV Cohort Study 1988–2000. Schweiz Med Wochenschr 2000; 130: 1493–500.
  • Gordon SM, Thompson S. The changing epidemiology of human immunodeficiency virus infection in older persons. J Am Geriatr Soc 1995; 43: 7–9.
  • Gaeta TJ, LaPolla C, Melendez E. AIDS in the elderly: New York City vital statistics. J Emerg Med 1996; 14: 19–23.
  • Newcomer VD. Human immunodeficiency virus infection and acquired immunodeficiency syndrome in the elderly. Arch Dermatol 1997; 133: 1311–2.
  • Rosenzweig R, Fillit H. Probable heterosexual transmission of AIDS in an aged woman. J Am Geriatr Soc 1992; 40: 1261–4.
  • Wallace JI, Paauw DS, Spach DH. HIV infection in older patients: when to suspect the unexpected. Geriatrics 1993; 48: 61–70.
  • Collaborative Group on AIDS Incubation and HIV Survival. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Lancet 2000; 355: 1131–7.
  • Drugs against HIV infection (Médicaments contre les infections par le VIH). Med Lett Drug Ther 2000; 22: 13–8.
  • Justice AC, Whalen C. Aging in AIDS; AIDS and aging. J Gen Intern Med 1996; 11: 645–7.
  • Noskin GA, Galssroth J. Pulmonary infections in HIV-1 infected patients. Eur Respir Mon 1995; 2: 255–85.
  • Sudre P, Hirschel B, Toscani L, Lederberger B, Rieder HL. Risk factors for tuberculosis among HIV-infected patients in Switzerland. Swiss HIV Cohort Study. Eur Respir J 1996; 9: 279–83.
  • Glatt AE, Anand A. Thrombocytopenia in patients infected with human immunodeficiency virus: treatment update. Clin Infect Dis 1995; 21: 415–23.
  • Dominguez A, Gamallo G, Garcia R, Lopez-Pastor A, Pena JM, Vazquez JJ. Pathophysiology of HIV related thrombocytopenia: an analysis of 41 patients. J Clin Pathol 1994; 47: 999–1003.

References

  • Bernstein JM. Treatment of community-acquired pneumonia – IDSA guidelines. Chest 1999; 115: 9–13S.
  • Bartlett JG, Breiman RF, Mandell LA, File TM Jr. Community acquired pneumonia in adults: guidelines for management. Clin Infect Dis 1998; 26: 811–38.
  • American Thoracic Society. Guidelines for the initial management of adults with community acquired pneumonia: diagnosis, assessment of severity and initial antimicrobial therapy. Am Rev Respir Dis 1993; 148: 1418–26.
  • Williams J, Tallis G, Dalton C, Sally Ng, Beaton S, Catton M, et al. Community outbreak of psittacosis in a rural Australian town. Lancet 1998; 351: 1697–9.
  • Schlossberg D. Chlamydia psittaci. In: Mandell, Douglas and Bennett’s principles and practice of infectious diseases. Edinburgh: Churchill Livingstone; 2000. p. 2005.
  • Lynch DA, Armstrong JD. A pattern-oriented approach to chest radiographs in atypical pneumonia syndromes. Clin Chest Med 1991; 12: 203–22.
  • Goupil F, Pelle-Duporte, Kouyoumdjian S, Carbonelle B, Tuchais E. Pneumopathies sévères d’allure pneumonique, au cours d’une épidémie d’ornithose. Presse Med 1998; 27: 1084–8.
  • Ekman MR, Leinonen M, Syrjälä H, Linnanmäki E, Kujala P, Saikku P. Evaluation of serological methods in the diagnosis of Chlamydia pneumoniae pneumonia during an epidemic in Finland. Eur J Clin Microbiol Infect Dis 1993; 12: 756–60.
  • Buys H, Zijderveld van F, Smith H. A PCR method to detect Chlamydia psittaci in faeces of infected birds. Ned Tijd Med Microbiol 2002; 10: S20.
  • Hewinson RG, Griffiths PC, Bevan BJ, Kirwan SES, Field ME, Woodward MJ, Dawson M. Detection of Chlamydia psittaci DNA in avian clinical samples by polymerase chain reaction. Vet Microbiol 1997; 54: 155–66.

References

  • Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 1995; 8: 451–61.
  • Miyashita N, Niki Y, Nakajima M, Fukano H, Matsushima T. Prevalence of asymptomatic infection with Chlamydia pneumoniae in subjectively healthy adults. Chest 2001; 119: 1416–9.
  • Gaillat J. Clinical manifestations of Chlamydia pneumoniae infections. Rev Med Interne 1996; 17: 987–91.
  • Ljungstrom L, Franzen C, Schlaug M, Elowson S, Viidas U. Reinfection with Chlamydia pneumoniae may induce isolated and systemic vasculitis in small and large vessels. Scand J Infect Dis Suppl 1997; 104: 37–40.
  • Sundelof B, Gnarpe H, Gnarpe J. An unusual manifestation of Chlamydia pneumoniae infection: meningitis, hepatitis, iritis, and atypical erythema nodosum. Scand J Infect Dis 1993; 25: 259–61.
  • Fiorini G, Bernasconi P, Sinico RA, Chianese R, Pozzi F, D’Amico G. Increased frequency of antibodies to ubiquitous viruses in essential mixed cryoglobulinemia. Clin Exp Immunol 1986; 64: 65–70.
  • Schaad UB, Rossi E. Infantile chlamydial pneumonia – a review based on 115 cases. Eur J Paediatr 1982; 138: 105–9.
  • Braun J, Laitko S, Treharne J, Eggens U, Wu P, Distler A, Sieper J. Chlamydia pneumoniae – a new causative agent of reactive arthritis and undifferentiated oligoarthritis. Ann Rheum Dis 1994; 53: 100–5.
  • Genereau T, Tri N’Guyen Q, Lortholary O, Cohen P, Guillevin L. Vasculitis of viral origin. Pathogenesis and therapeutic implications. J Mal Vasc 1995; 20: 1–7.

References

  • Guzmán MG, Kourí G. Dengue: an update. Lancet Infect Dis 2001; 2: 33–42.
  • Gubler DJ. The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res 2002; 33: 330–42.
  • Jelinek T. Dengue fever in international travelers. Clin Infect Dis 2000; 31: 144–7.
  • Rosen L. Disease exacerbation caused by sequential dengue infection: myth or reality? Rev Infect Dis 1989; 11: 840–2.
  • Cardosa MJ. Dengue haemorrhagic fever: questions of pathogenesis. Curr Opin Infect Dis 2000; 13: 471–5.
  • Guzman JR, Kron MA. Threat of dengue haemorrhagic fever after yellow fever vaccination. Lancet 1997; 349: 1841.
  • World Health Organization. Dengue haemorrhagic fever: diagnosis, treatment and control. 2nd edn. Geneva: World Health Organization; 1997. p. 34–47.
  • Jelinek T, Muhlberger N, Harms G, Corachan M, Grobusch MP, Knobloch J, et al. European Network on Imported Infectious Disease Surveillance. Epidemiology and clinical features of imported dengue fever in Europe: sentinel surveillance data from TropNetEurop. Clin Infect Dis 2002; 35: 1047–52.
  • Teichmann D, Rogler G, Grobusch MP, Schuler-Maue W, Klein E. Imported dengue virus type 2 infection acquired during an outbreak in India. Eur J Clin Microbiol Infect Dis 1999; 18: 310–2.
  • World Health Organization. Dengue and dengue haemorrhagic fever. World Health Organization. Fact Sheet, 2002; No. 117.
  • Malheiros SM, Oliveira AS, Schmidt B, Lima JG, Gabbai AA. Dengue. Muscle biopsy findings in 15 patients. Arq Neuropsiquiatr 1993; 51: 159–64.
  • Massad E, Coutinho FA, Burattini MN, Lopez LF. The risk of yellow fever in a dengue-infested area. Trans R Soc Trop Med Hyg 2001; 95: 370–4.

References

  • Davis BR. Filariases. Dermatol Clin 1989; 7: 313–21.
  • Pinon JM, Dousset H, Ologoudou L, Sulahian A, Adnet J-J. Dirofilariasis of the breast in France (Brief communication). Am J Trop Hyg 1980; 29: 1018–9.
  • Kranjcic-Zec I, Mitrovic S, Arsic V, Dra’ic A, Radojicic B. Subperiostal nodule in human caused by Dirofilaria sp. VIII International Congress of Parasitology, Izmir, Turkey; 1944. POH–33.
  • Masseron T, Sailliol A, Niel L, Floch J-J. Dirofilariose conjonctivale a dirofilaria repens: a propos d’un cas francais. Med Trop 1996; 457–8.
  • Beaver PC. Intraocular filariasis: a brief review. Am J Trop Med Hyg 1989; 40: 40–5.

References

  • DuPont HL. Shigella. Infect Dis Clin North Am 1988; 2: 599–605.
  • Barrett-Connor E, Connor JD. Extraintestinal manifestations of shigellosis. Am J Gastroenterol 1970; 53: 234–45.
  • Galanakis E, Tzoufi M, Charisi M, Levidiotou S, Papadopoulou ZL. Rate of seizures in children with shigellosis. Acta Paediatr 2002; 91: 101–2.
  • Jao RL, Jackson GG. Asymptomatic urinary-tract infection with Shigella sonnei in a chronic fecal carrier. N Engl J Med 1963; 268: 1165–8.
  • Ekwall E, Ljungh A, Selander B. Asymptomatic urinary tract infection caused by Shigella sonnei. Scand J Infect Dis 1984; 16: 121–2.
  • Narchi H, Beattie TJ. Asymptomatic bacteriuria with Shigella sonnei. Pediatr Nephrol 1987; 1: 306–7.
  • Awadalla NB, Johny M. Urinary tract infection caused by Shigella sonnei: a case report. Ann Trop Paediatr 1990; 10: 309–11.
  • Papasian CJ, Enna-Kifer S, Garrison B. Symptomatic Shigella sonnei urinary tract infection. J Clin Microbiol 1995; 33: 2222–3.
  • Murphy TV, Nelson JD. Shigella vaginitis: report on 38 patients and review of the literature. Paediatrics 1979; 63: 511–6.
  • Barret-Connor E, Connor JD. Extraintestinal manifestations of shigellosis. Am J Gastroenterol 1970; 53: 234–45.
  • Replogle ML, Fleming DW, Cieslak PR. Emergence of antimicrobial-resistant shigellosis in Oregon. Clin Infect Dis 2000; 30: 515–9.
  • Maraki S, Georgiladakis A, Christidou A, Scoulica E, Tselentis Y. Antimicrobial susceptibilities and beta-lactamase production of Shigella isolates in Crete, Greece, during the period 19911995. APMIS 1998; 106: 879–83.

References

  • Adams WC, Hindman SM. Cat-scratch disease associated with an osteolytic lesion. J Pediatr 1954; 44: 665–9.
  • Raynoad V, Geffray L, Collet T, Huet H, Parienti J-J, Debruyne M, et al. Vertebral osteomyelitis due to Bartonella henselae in adults: a report of 2 cases. Clin Infect Dis 2002; 35: e141–4.
  • Slater LN, Welch DF. Bartonella species, including cat scratch disease. In: Mandell G, Bennett J, Dolin R, eds. Principles and practice of infectious diseases, 5th edn. Philadelphia, PA: Churchill Livingstone; 2000. p. 2444–56.
  • Nadal D, Zbinden R. Serology to Bartonella (Rochalimaea) henselae may replace traditional diagnostic criteria for catscratch disease. Eur J Pediatr 1995; 154: 906–8.
  • Avidor B, Kletter Y, Abulatia S, Golan Y, Ephros M, Giladi M. Molecular diagnosis of cat-scratch disease: a two step approach. J Clin Microbiol 1997; 35: 924–30.
  • Bergmans AMC, Peeters MF, Schellekens JFP, et al. Pitfalls and fallacies of cat-scratch disease serology: evaluation of Bartonella henselae based indirect fluorescence assay and enzyme-linked immunoassay. J Clin Microbiol 1997; 35: 1931–7.
  • Wilson SM, McNerney R, Nye PM, Godfrey-Faussett PD, Stoker NG, Voller A. Progress toward a simplified polymerase chain reaction and its application to diagnosis of tuberculosis. J Clin Microbiol 1993; 31: 776–82.
  • Matar GM, Swaminathan B, Hunter SB, Slater LN, Welch DF. Polymerase chain reaction-based restriction fragment length polymorphism analysis of a fragment of the ribosomal operon from Rochalimaea species for subtyping. J Clin Microbiol 1993; 11: 1730–4.
  • La Scola B, Raoult D. Culture of Bartonella quintana and Bartonella henselae from human samples: a 5-year experience (1993 to 1998). J Clin Microbiol 1999; 37: 1899–905.
  • Modi SP, Eppes SC, Klein JD. Cat-scratch disease presenting as multifocal osteomyelitis with thoracic abscess. Pediatr Infect Dis J 2001; 20: 1006–7.
  • Margileth AM. Antibiotic therapy for cat-scratch disease; clinical study of therapeutic outcome in 268 patients and a review of the literature. Pediatr Infect Dis J 1992; 11: 474–8.
  • Conen-abbo A, Cheatham J, Edwards K. Disseminated catscratch disease simulating neuroblastoma. Pediatr Infect Dis J 1992; 11: 1058–60.
  • Luddy RE, Sutherland JC, Levy BE, Schwartz AD. Cat scratch disease simulating malignant lymphoma. Cancer 1982; 50: 585–6.
  • Milllot F, Tailbent L, Paccalir M. Cat-scratch disease simulating a malignant process of the chest wall. Eur J Pediatr 1999; 158: 403–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.